Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) announced that it has launched a new human genetics initiative via a new wholly owned ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE